| Prev Close | 232.89 |
| Day Low/High | 233.74 / 242.62 |
| 52 Wk Low/High | 225.65 / 355.88 |
Humana Inc. (HUM)
240.69
NYSE
| Exchange | NYSE |
| Shares Outstanding | 135.64B |
| Market Cap | 31.59B |
| Div & Yield | N.A. (N.A) |
Latest News
Jim Cramer: Why Wouldn't You Own Apple Stock?
Has the sun set on what was the greatest wealth creator of any company when the stock traded north of a trillion dollars? No.
Jim Cramer: What to Buy in This Treacherous Market
Look for the big-cap stocks that only come in on tough days -- and take advantage of their weakness at the open.
Winners and Losers of Political Gridlock: Market Recon
Infrastructure and health care are likely to be in the political spotlight.
Jim Cramer: Why the Market Did What It Did Today and What Can Happen Tomorrow
Now for those of you haven't voted, please go and do so and don't vote this stuff just invest in it!
Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter
Straying from these names could land you in quicksand as the 4th quarter begins.
Jim Cramer: Valuations Now Have No Relation to Common Sense
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop
It is all about perception, and here are strong names to pick up on market weakness.
5 Defense Stocks to Buy Now: Market Recon
Today's headlines may bring uncertainty, but this sector still looks good.
Jim Cramer: When Rates Decline, 96% of the S&P 500 Benefits
When rates decline, most of the S&P 500 benefits, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.
4 Healthcare Stocks for a Declining Rate Environment
Examining the charts of several names that are being bought and how to play them.
Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back
The crash of oil will only accelerate the move.
We Are Never Going Back to Easy Markets: Market Recon
Consistency in discipline will make the difference.
The Long-Term Bull Driving Humana Is Back With New Price Targets
Let's look further.
15 Sectors to Buy on a U.S./Chinese Trade War (Part I)
These areas have little exposure to China, so buy them on any broad-market dip over U.S.-Chinese trade tensions.
Second Quarter Predictions
Better-than-expected earnings will help soothe market jitters in the second quarter.
China Announces New Tariffs and 4 Other Stories You Need to Know Monday Morning
Are you ready to trade Monday? Here's what you must know as Wall Street returns from its long weekend.
Humana Rally At Risk
Volume has been declining, making shares vulnerable to declines.
Bullish Humana Stock Should Keep 'HUM'ming Along
The shares experienced a small 'hiccup' Tuesday.
Closing Bell: LIVE MARKETS BLOG
The Dow dropped more than 300 points Tuesday.
Cramer: How to Play the Volatility in UnitedHealth and Others
Even if you love a stock that's down today, don't dive in all at once.
Video: Bonuses Are Great But Where Are The Actual Wage Increases?
Sure, we love that companies are giving out one-time bonuses thanks to the lower rates from tax reform. But where are the actual wage increases? Watch out this video to find out.
Stocks Sink Ahead of Tax Bill Vote
Shares of Kindred Healthcare slipped after reaching an agreement to be acquired in a $4.1 billion deal.
Hershey, Bitcoin and Everything Else You Need to Know in 60 Seconds
Here's everything you need to get ready for the final trading week before the holidays.
Jim Cramer: It's That Time When Losers Win in the Stock Market
Corporate buyers are now coming after sub-par companies.
Why CVS/Aetna Could Be a Game Changer -- Who Sells Out Next May Shock You
This could also set off a chain reaction of similar deals.
Watch: Former Humana Executive Supports the CVS-Aetna Deal
Paul Kusserow, CEO of home health care provider Amedysis and a former Humana executive, thinks CVS Health's agreement to buy Aetna, announced on Monday, is "very exciting."
